InvestorsHub Logo
Followers 0
Posts 25
Boards Moderated 0
Alias Born 08/25/2017

Re: blu_1 post# 124350

Thursday, 10/12/2017 4:50:13 PM

Thursday, October 12, 2017 4:50:13 PM

Post# of 455264
I would like to see references for that. Per these studies, donepezil results usually in a slight decline in MMSE at about 12 months, which is the same as what 2-73 accomplished for the average of all patients in the 52 (57) week results. And it performs better than placebo in that time frame.

https://www.medscape.org/viewarticle/481063_5

https://www.medscape.com/viewarticle/507510_3

https://www.researchgate.net/publication/6494106_Donepezil_in_Alzheimer's_Disease_What_to_Expect_after_3_Years_of_Treatment_in_a_Routine_Clinical_Setting
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News